drugset / Trial / NCT05870553

A Phase 3 Trial in Bowel Preparation for Colonoscopy

NCT05870553

Phase 3 Completed 137 enrolled Taejoon Pharmaceutical Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

Timeline

Start
2023-01-30
Primary completion
2023-05-12
Completion
2023-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP0301-B Unknown
Comparator Coolprep Unknown
Subject polyethylene glycol Other / unclassified

Indications

No indication recorded.